Brief: Century Therapeutics Reports Q1 2023 Financial Results And Provides Business Updates
11/05/2023 12:48
May 11 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* CENTURY THERAPEUTICS INC - ENDED Q1 2023 WITH CASH, CASH
EQUIVALENTS, AND INVESTMENTS OF $334.8 MILLION
* CENTURY THERAPEUTICS INC - CASH RUNWAY EXPECTED INTO 2026
* CENTURY THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.53
Source text for Eikon: ID:nGNX1kfpfv
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview